Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Osiris Therapeutics (NASDAQ: OSIR)

Last Updated: Feb-22-2017 09:29:38

OSIR News & Stock Updates

Premium Research

Osiris Therapeutics (NASDAQ: OSIR) Profile

Prior Close$5.87
Market Cap$0.19 B
PE Ratio
OSIRIS THERAPEUTICS INC. is a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory orthopedic and cardiovascular areas. Osiris currently markets and sells Osteocel for regenerating bone in orthopedic indications. Prochymal is being evaluated in Phase III clinical trials for three indications including acute and steroid refractory Graft versus Host Disease and also Crohn's disease and is the only stem cell therapeutic currently designated by FDA as both an Orphan Drug and Fast Track product. Osiris also has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies. Osiris is a fully integrated company having developed capabilities in research development manufacturing marketing and distribution of stem cell products.
SymbolCompanyMarket cap
AMGNAmgen$127.62 B
CELGCelgene Corp$94.26 B
GILDGilead Sciences Inc$91.5 B
BIIBBiogen Inc Cmn$62.4 B
REGNRegeneron Pharmaceutical$39.15 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$28.93 B
ILMNIllumina Inc$23.9 B
INCYIncyte Corporation$22.82 B
VRTXVertex Pharmaceutic$21.93 B

OSIR Earnings

1st Quarter Earnings$ ()
2nd Quarter Earnings$ ()
3rd Quarter Earnings$ ()
4th Quarter Earnings$ ()
PE Ratio0
EPS Growth0%
Recent Earnings$
Annual EPS$0
Market Capitalization$0.19 B
Insider Shareholder %0.446%
Annual Revenue$0 B
Number of Shares Outstanding34,450 Shares
Institutional Shareholder %19.88%
Annual Net Income$0B
TTM Net Profit Margin$100
One Year Return-20.35%
Three Year Return-66.15%
Five Year Return20.78%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$
Annual EPS$0
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD%
PE Ratio
Recent Earnings$
Dividends per Share$
Stock Split Ratio

OSIR Key Stats

Last Price$5.55
Net Change$-0.32 (-5.45%)
Ask Price$5.6
Open Price$5.76
Previous Close Price$5.87
High Price$5.88
Low Price$5.54
Number of Trades96
Fifty Two Week High$7.87 (2016-03-08)
Fifty Two Week Low$3.55 (2016-03-16)
Average Daily Volume86,042
Share Outstanding34,450 Shares
Total Dividend Payout$0/yr
Dividend Yield0%